Palladium-Catalyzed Intramolecular Asymmetric Allylic Amidation: A General Route to 5-Substituted Chiral Oxazolines.

Yong Su, Xu Bao

Abstract read

In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yong SuState Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.

Xu BaoState Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0001-9359-1951

Funding

Funda-mental Research Funds for the Central Universities lzujbky-2023-ct02National Natural Science Foundation of China 22471107the Science and Technology Program of Gansu Province of China 22ZD6FA006the Science and Technology Program of Gansu Province of China 23ZDFA015the Science and Technology Program of Gansu Province of China 24ZD13FA017the Science and Technology Program of Gansu Province of China 24ZDFA003

6 · The paper itself

Abstract

A general and modular catalytic enantioselective route to 5-substituted chiral oxazolines has been developed via palladium-catalyzed intramolecular asymmetric allylic amidation. This strategy employs readily available racemic 2-substituted-5-styryl oxazolidinones as substrates. Key to the success is the identification of a sterically hindered biphenol-derived phosphoramidite ligand, which, in combination with Pd

Indexed as

asymmetric allylic amidationchiral oxazolinesenantioselectivityoxazolidinonespalladium

Identifiers

PMID42033244

DOI10.1002/chem.71046

PMCPMC13356352

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.